Modulating Toll-like Receptor Activity via CXCR4 Binding Agents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively modulate Toll-like receptor (TLR) activity, which is crucial for immune responses, as they do not adequately address the need to enhance or suppress immune reactions in response to foreign agents or inflammatory conditions.
Innovation Solution
The use of CXCR4 binding agents, such as anti-CXCR4 antibodies and CXCR4 ligands, to modulate Toll-like receptor activity by interacting with CXCR4 polypeptides, thereby influencing the response to Toll-like receptor agonists like LPS, either increasing or decreasing the activation level.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If CXCR4 binding agents are used to modulate TLR activity, then immune response control is improved, but device complexity increases
Solution Approach 1:
The patent uses CXCR4 binding agents as intermediary molecules that indirectly modulate TLR activity by binding to CXCR4 receptors. This mediator approach allows control of immune responses without directly targeting TLRs, providing a novel pathway for immune modulation while maintaining system reliability.
2Reliability
If TLR responsiveness is increased to enhance foreign agent detection, then immune defense capability is improved, but inflammation severity worsens
Solution Approach 1:
The patent employs dynamic modulation of TLR responsiveness through CXCR4 binding agents, allowing the immune system to adapt its response intensity. By dynamically adjusting TLR activity levels based on CXCR4 binding, the system can enhance foreign agent detection when needed while preventing excessive inflammation, thus resolving the contradiction between detection capability and inflammation control.
3Object-affected harmful factors
If TLR activity is suppressed to reduce inflammation, then inflammation control is improved, but immune response effectiveness worsens
Solution Approach 1:
The patent changes the parameter of TLR activity through CXCR4 binding agent modulation. By altering the activation state of CXCR4 receptors, the system can adjust TLR responsiveness parameters to achieve appropriate inflammation control while preserving necessary immune response effectiveness, thus resolving the contradiction between inflammation suppression and immune functionality.
Data Source
AI summary
This description provides methods and materials related to modulating Toll-like receptor activity. For example, methods and materials for increasing or decreasing the responsiveness of a TLR4 polypeptide are provided.